The subject invention provides advantageous new salts of mu-opiate receptorpeptides. These salts have been foundto have excellent properties in terms of their crystal structure, stability,solubility, lack of impurities and/or the ability to be produced,with these advantageous properties, in amounts sufficient for the productionof therapeutic compositions.
